2.03

1.93% -0.04

Clearmind Medicine Inc (CMND)

Panoramica Notizia Cronologia dei prezzi Perché CMND Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$2.07

Aprire:

$2.07

Volume 24 ore:

95,877

Relative Volume:

0.04

Capitalizzazione di mercato:

$3.02M

Reddito:

Utile/perdita netta:

$-6.64M

Rapporto P/E:

-0.0113

EPS:

-179.3009

Flusso di cassa netto:

$-5.60M

1 W Prestazione:

-13.98%

1M Prestazione:

-36.56%

6M Prestazione:

-91.36%

1 anno Prestazione:

-99.48%

Intervallo 1D:

$2.03

$2.15

Intervallo di 1 settimana:

$2.00

$2.35

Portata 52W:

$2.00

$524.00

Clearmind Medicine Inc Stock (CMND) Company Profile

Nome

Clearmind Medicine Inc

Settore

Healthcare (1096)

Industria

Biotechnology (616)

Telefono

Indirizzo

Dipendente

Cinguettio

Prossima data di guadagno

2026-06-11

Ultimi documenti SEC

CMND's Discussions on Twitter

Compare CMND vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CMND Clearmind Medicine Inc	2.03	3.02M	0	-6.64M	-5.60M	-179.30
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Clearmind Medicine Inc Borsa (CMND) Ultime notizie

Jul 10, 2026

Clearmind Medicine Submits Formal Response To HHS RFI Highlighting MEAI-Based Candidate CMND-100 For Alcohol Use Disorder And Binge Behaviors - marketscreener.com

Jul 10, 2026

Clearmind submits addiction treatment proposal to U.S. HHS - Investing.com India

Jul 10, 2026

Clearmind submits MEAI addiction treatment prop... - Pluang

Jul 10, 2026

Clearmind Medicine Submits Response to HHS RFI Highlighting MEAI-Based CMND-100 for Alcohol Use Disorder - Quiver Quantitative

Jul 10, 2026

Jul 07, 2026

Clearmind Medicine (CMND) reports successful intranasal MEAI feasibility study - Stock Titan

Jul 07, 2026

Clearmind Medicine : Reports Successful Formulation Feasibility Study Supporting Potential New Additional Route of Administration for MEAI - marketscreener.com

Jul 07, 2026

CMND Stock Slides As Traders Gauge Cash Runway And Volatility - StocksToTrade

Jul 07, 2026

Clearmind Medicine Reports Successful Formulation Feasibility for Intranasal MEAI Development Program for Alcohol Use Disorder - Quiver Quantitative

Jul 07, 2026

Clearmind Reports Successful Formulation Feasibility Study Supporting Potential New Additional Route of Administration Development for MEAI - Yahoo Finance UK

Jul 07, 2026

Clearmind Medicine Company Profile & Introduction - Moomoo

Jul 07, 2026

Jul 02, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jul 02, 2026

Jun 29, 2026

Clearmind Medicine receives U.S. patent for binge behavior treatment - Investing.com UK

Jun 29, 2026

Clearmind Medicine receives U.S. patent for binge behavior treatment By Investing.com - Investing.com Australia

Jun 29, 2026

Clearmind Medicine Advances Its Innovation with Newly Granted U.S. Patent, Enhancing Global Patent Strength - The Manila Times

Jun 29, 2026

Jun 27, 2026

Clearmind Medicine(CMND) Stock Options Chain | Quotes & News - Moomoo

Jun 27, 2026

Jun 26, 2026

Price to earnings forward of Clearmind Medicine Inc. – MUN:CWY0 - TradingView

Jun 26, 2026

Jun 25, 2026

Price to earnings forward of Clearmind Medicine Inc. – NASDAQ:CMND - TradingView

Jun 25, 2026

Enterprise value to revenue forward of Clearmind Medicine Inc. – NASDAQ:CMND - TradingView

Jun 25, 2026

Jun 24, 2026

Price to sales forward of Clearmind Medicine Inc. – NASDAQ:CMND - TradingView

Jun 24, 2026

Price to book forward of Clearmind Medicine Inc. – NASDAQ:CMND - TradingView

Jun 24, 2026

Jun 23, 2026

Clearmind Medicine Reaches Major Milestone, Completing Part a Treatment in FDA-Regulated Phase I/II Trial - marketscreener.com

Jun 23, 2026